Panbela Therapeutics (PBLA) Short Interest Ratio & Short Volume $0.16 -0.01 (-7.12%) As of 10:01 AM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Panbela Therapeutics Short Interest DataPanbela Therapeutics (PBLA) has a short interest of 200 shares. This marks a 100.00% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 17,141 shares to cover all short positions.Current Short Interest200 sharesPrevious Short Interest100 sharesChange Vs. Previous Month+100.00%Dollar Volume Sold Short$47.88Short Interest Ratio0.0 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares4,855,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume1,658 sharesAverage Trading Volume17,141 sharesToday's Volume Vs. Average10% Short Selling Panbela Therapeutics? Sign up to receive the latest short interest report for Panbela Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPBLA Short Interest Over TimePBLA Days to Cover Over TimePBLA Percentage of Float Shorted Over Time Panbela Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/2025200 shares $47.88 +100.0%N/A0 $0.24 6/30/2025100 shares $23.19 -50.0%0.0%0 $0.23 6/15/2025200 shares $60.00 No Change0.0%0 $0.30 5/31/2025200 shares $51.60 +100.0%0.0%0 $0.26 5/15/2025100 shares $30.00 -93.8%N/A0 $0.30 4/30/20251,600 shares $424.00 No ChangeN/A0.1 $0.27 4/15/2025100 shares $31.30 -66.7%N/A0 $0.31 3/14/2025300 shares $111.30 -95.5%N/A0 $0.37 2/14/2025300 shares $102.00 -25.0%N/A0 $0.34 1/31/2025400 shares $140.00 -94.0%N/A0 $0.35 Get the Latest News and Ratings for PBLA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Panbela Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/20256,700 shares $2.81 thousand +6,600.0%N/A0.1 $0.42 2/29/2024114,700 shares $135.35 thousand +7.2%2.4%0.1 $1.18 2/15/2024107,000 shares $135.89 thousand -39.8%2.2%0.1 $1.27 1/31/2024177,700 shares $247.00 thousand +283.0%3.7%0.3 $1.39 1/15/202446,400 shares $584.64 thousand -96.6%9.7%0.2 $12.60 12/31/20231,350,000 shares $1.24 million +1,319.6%14.1%0.3 $0.92 12/15/202395,100 shares $43.47 thousand +115.7%1.9%0 $0.46 11/30/202344,100 shares $23.37 thousand -32.1%0.9%0 $0.53 11/15/202364,900 shares $39.13 thousand -22.2%1.3%0.1 $0.60 10/31/202383,400 shares $66.90 thousand +22.5%2.8%0.1 $0.80 10/15/202368,100 shares $70.14 thousand -21.5%2.3%0.6 $1.03 9/30/202386,700 shares $113.58 thousand -18.2%3.0%0.1 $1.31 9/15/2023106,000 shares $139.92 thousand +26.6%3.6%0.1 $1.32 8/31/202383,700 shares $116.34 thousand +335.9%2.9%0.1 $1.39 8/15/202319,200 shares $28.80 thousand -60.5%0.7%0 $1.50 7/31/202348,600 shares $97.69 thousand +102.5%1.7%0.1 $2.01 7/15/202324,000 shares $49.92 thousand -74.6%0.9%0 $2.08 6/30/202394,600 shares $217.58 thousand -50.3%3.4%0.4 $2.30 6/15/2023190,500 shares $1.11 million +590.2%6.9%0.9 $5.81 5/31/202327,600 shares $186.38 thousand -96.3%5.1%0.2 $6.75 5/15/2023754,400 shares $309.30 thousand -59.9%N/A0.3 $0.41 4/30/20231,880,000 shares $1.03 million -23.0%N/A0.6 $0.55 4/15/20232,440,000 shares $1.39 million +611.6%N/A0.9 $0.57 3/31/2023342,900 shares $151.63 thousand +3.9%N/A0.1 $0.44 3/15/2023330,200 shares $219.55 thousand -61.6%N/A0.2 $0.66 2/28/2023859,300 shares $1.18 million -18.2%13.7%0.5 $1.37 2/15/20231,050,000 shares $1.52 million +596.8%16.7%0.7 $1.45 1/31/2023150,700 shares $247.15 thousand -63.9%2.5%0.1 $1.64 1/15/2023417,700 shares $1.39 million -67.4%55.4%1.2 $3.32 12/30/20221,280,000 shares $93.82 thousand +60.5%N/A0.2 $0.07Why AMZN, GOOG, MSFT might destroy NVDA (Ad)Investing Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.Click to get the full details on Eric Fry's "Nvidia alternative" right here. 12/15/2022797,500 shares $77.36 thousand +227.1%N/A0.2 $0.10 11/30/2022243,800 shares $33.01 thousand +354.9%N/A0.2 $0.14 11/15/202253,600 shares $8.52 thousand +51.8%N/A0.1 $0.16 10/31/202235,300 shares $4.47 thousand -23.9%N/A0 $0.13 10/15/202246,400 shares $10.35 thousand -95.6%N/A0.1 $0.22 9/30/20221,050,000 shares $283.82 thousand +276.9%N/A1.7 $0.27 9/15/2022278,600 shares $105.59 thousand +101.0%N/A0.5 $0.38 8/31/2022138,600 shares $95.74 thousand +9.4%N/A2.4 $0.69 8/15/2022126,700 shares $150.77 thousand -24.0%N/A2.7 $1.19 7/31/2022166,700 shares $206.71 thousand -4.9%N/A3.7 $1.24 7/15/2022175,300 shares $194.58 thousand +19.7%N/A3.9 $1.11 6/30/2022146,400 shares $96.64 thousand -4.6%N/A3.1 $0.66 6/15/2022153,500 shares $193.41 thousand +1.2%N/A4.4 $1.26 5/31/2022151,700 shares $227.55 thousand +31.0%N/A8.6 $1.50 5/15/2022115,800 shares $185.53 thousand -18.6%N/A4.1 $1.60 4/30/2022142,200 shares $251.69 thousand -14.3%N/A4.3 $1.77 4/15/2022165,900 shares $328.48 thousand +3.3%N/A4.5 $1.98 3/31/2022160,600 shares $338.87 thousand +9.9%N/A4.3 $2.11 3/15/2022146,200 shares $248.54 thousand -15.3%N/A3.2 $1.70 2/28/2022172,600 shares $336.57 thousand +21.8%N/A3.3 $1.95 2/15/2022141,700 shares $317.41 thousand -18.1%N/A2.4 $2.24 1/31/2022173,100 shares $368.70 thousand -6.2%N/A3.1 $2.13 1/15/2022184,600 shares $304.59 thousand -17.7%N/A3.3 $1.65 12/31/2021224,200 shares $387.89 thousand +18.9%N/A4.1 $1.73 12/15/2021188,600 shares $330.05 thousand -10.6%N/A3.7 $1.75 11/30/2021211,000 shares $390.35 thousand +5.3%N/A4.1 $1.85 11/15/2021200,300 shares $426.64 thousand -0.7%N/A3.5 $2.13 10/29/2021201,800 shares $431.85 thousand -1.5%N/A3.6 $2.14 10/15/2021204,900 shares $405.70 thousand +5.2%N/A1.6 $1.98 9/30/2021194,800 shares $422.72 thousand -9.4%N/A1.3 $2.17 9/15/2021214,900 shares $472.78 thousand -2.5%N/A0.9 $2.20 8/31/2021220,500 shares $500.54 thousand -14.7%N/A0.9 $2.27 8/13/2021258,400 shares $607.24 thousand +5.7%N/A1.1 $2.35 7/30/2021244,400 shares $615.89 thousand +12.5%N/A1 $2.52 7/15/2021217,200 shares $562.55 thousand -35.5%N/A1.3 $2.59 6/30/2021336,500 shares $952.30 thousand +85.2%N/A2.1 $2.83 6/15/2021181,700 shares $675.92 thousand -6.2%2.2%2.7 $3.72 5/28/2021193,800 shares $813.96 thousand +6.9%2.3%3 $4.20 5/14/2021181,300 shares $692.57 thousand -14.0%2.2%3.2 $3.82 4/30/2021210,900 shares $982.79 thousand +18.2%2.5%1.8 $4.66 4/15/2021178,400 shares $713.60 thousand -5.2%2.1%1.1 $4.00 3/31/2021188,100 shares $769.33 thousand -3.9%2.3%1.2 $4.09 3/15/2021195,700 shares $884.56 thousand +16.6%2.4%1.2 $4.52 2/26/2021167,800 shares $740.00 thousand -12.2%2.2%0.8 $4.41 2/12/2021191,000 shares $1.03 million +38.3%2.5%1 $5.38 1/29/2021138,100 shares $760.24 thousand +78.9%1.8%0.9 $5.51 1/15/202177,200 shares $633.04 thousand No Change1.0%0.8 $8.20 PBLA Short Interest - Frequently Asked Questions What is Panbela Therapeutics' current short interest? Short interest is the volume of Panbela Therapeutics shares that have been sold short but have not yet been covered or closed out. As of July 15th, investors have sold 200 shares of PBLA short. Learn More on Panbela Therapeutics' current short interest. Is Panbela Therapeutics' short interest increasing or decreasing? Panbela Therapeutics saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 200 shares, an increase of 100.0% from the previous total of 100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Panbela Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Panbela Therapeutics: PMGC Holdings Inc. (17.44%), Enveric Biosciences, Inc. (9.98%), Windtree Therapeutics, Inc. (71.04%), Galmed Pharmaceuticals Ltd. (6.25%), PainReform Ltd. (7.91%), CERo Therapeutics Holdings, Inc. (1.50%), Heatwurx Inc. (24.33%), Can-Fite BioPharma Ltd. (2.64%), Aditxt, Inc. (6.30%), AIM ImmunoTech Inc. (414.92%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Panbela Therapeutics stock? Short selling PBLA is an investing strategy that aims to generate trading profit from Panbela Therapeutics as its price is falling. PBLA shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Panbela Therapeutics? A short squeeze for Panbela Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PBLA, which in turn drives the price of the stock up even further. How often is Panbela Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PBLA, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies PMGC Short Interest Data Enveric Biosciences Short Interest Data Windtree Therapeutics Short Interest Data Galmed Pharmaceuticals Short Interest Data PainReform Short Interest Data CERo Therapeutics Short Interest Data Heatwurx Short Interest Data Can-Fite BioPharma Short Interest Data Aditxt Short Interest Data AIM ImmunoTech Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PBLA) was last updated on 8/5/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Panbela Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Panbela Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PBLA Stock Alerts